The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three
other myelomonocytic antigens ie CD33, CD14 and CD15 was analyzed by flow cytometry …

B-Chronic lymphocytic leukaemia (B-CLL) is a monoclonal malignancy characterized by an
accumulation of terminally differentiated small and anergic B lymphocytes in the blood, bone …

We have investigated the expression of the dual specific adhesion molecule, VLA-4
(CD49d/CD29) on lymphocytes obtained from 62 patients with B-CLL and compared it with …

BACKGROUND AND OBJECTIVE: Distinction between B-cell chronic leukemias can be
difficult due to overlap in cell morphology and immunologic features. We investigated, by …

The cross-lineage expression of five myelomonocytic antigens (CD11b, CD11c, CD13,
CD14, and CD15) was analysed in neoplastic lymphocytes from 100 consecutive B-cell …

CD31 is the physiological ligand for CD38. CD38 expression in a high percentage of
malignant cells is a risk factor for patients with B-cell chronic lymphocytic leukaemia (B-CLL) …

The aberrant expression of the myelomonocytic antigen CD14 was investigated in 128
untreated patients diagnosed with B‐cell chronic lymphocytic leukaemia (B‐CLL). A cut‐off …

CD52 is a glycoprotein expressed on normal as well as leukemic immune cells and shed as
soluble CD52 (sCD52). We studied sCD52 levels in three CLL cohorts: the 'early', the 'high …

Whole-blood three-color immunofluorescence analysis was used to investigate the role of
CD5/CD72 and CD21/CD23 receptor-ligand pair formation on B-chronic lymphocytic …

Differential expression of CD20 surface antigen in B-cell neoplasms at different sites is
largely unknown. The number of CD20 antibodies bound per cell (CD20 ABC) in bone …